Exact Mass: 420.10880760000003
Exact Mass Matches: 420.10880760000003
Found 79 metabolites which its exact mass value is equals to given mass value 420.10880760000003
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Bismurrayaquinone A
Bismurrayaquinone A is found in herbs and spices. Bismurrayaquinone A is an alkaloid from roots of Murraya koenigii (curryleaf tree). Alkaloid from roots of Murraya koenigii (curryleaf tree). Bismurrayaquinone A is found in herbs and spices.
Doripenem
Doripenem (common name doripenem monohydrate) is an ultra-broad spectrum injectable antibiotic. It is a beta-lactam and belongs to the subgroup of carbapenems. It was launched by Shionogi Co. of Japan under the brand name Finibax in 2005 and is being marketed outside Japan by Johnson & Johnson. It is particularly active against Pseudomonas aeruginosa. Doripenem is a beta-lactam antibiotic agent belonging to the carbapenem group, with a broad spectrum of bacterial sensitivity. Although doripenem may be quite similar to other related carbapenem agents, the antibiotic includes several divergent properties. For example, doripenem includes a transfiguration of hydroxyethyl group, and in position 4 there is a carbon atom. These differences make the agent more stable against other pathogens. Doripenem inhibits renal dehydropeptidase-1 hydrolysis due to its structure containing a single side chain, 1-beta methyl. Additionally, within the molecular structure a sulfamoylaminomethyl-pyrrolindinylthio group is attached to a side chain giving the molecule increased antibacterial action against gram-negative microbes. In vivo, doripenem inhibits the synthesis of cell walls by attaching itself to penicillin binding proteins, also known as PBPs. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DH - Carbapenems D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Sulfinpyrazone sulfone
C23H20N2O4S (420.11437200000006)
Sulfinpyrazone sulfone is a metabolite of sulfinpyrazone. Sulfinpyrazone is a uricosuric medication used to treat gout. It also sometimes is used to reduce platelet aggregation by inhibiting degranulation of platelets which reduces the release of ADP and thromboxane. Like other uricosurics, sulfinpyrazone works by competitively inhibiting uric acid reabsorption in the proximal tubule of the kidney. (Wikipedia)
Darglitazone
C23H20N2O4S (420.11437200000006)
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent Darglitazone (CP-86325), a thiazolidinedione, is a potent, selective, and orally active PPAR-γ agonist. Darglitazone is effective in controlling blood glucose and lipid metabolism, and can be used for type II diabetes research[1].
Desethyl kbt-3022
C23H20N2O4S (420.11437200000006)
4-Hydroxy-5-[[4-[3-(5-methyl-2-phenyl-1,3-oxazol-4-yl)propanoyl]phenyl]methyl]-3H-1,3-thiazol-2-one
C23H20N2O4S (420.11437200000006)
3-Demethyldigicitrin
5,5,7-trihydroxy-2,3,4,6,8-pentamethoxyflavone|5,7,5-trihydroxy-3,6,8,2,4-pentamethoxyflavone
cassiaside|nor-rubrofusarin-6-O-beta-D-glucopyranoside
N-Phenyl-N-(4-D-glucosidurono-phenyl)-thioharnstoff|N-Phenyl-N-<4-D-glucosidurono-phenyl>-thioharnstoff|N-Phenyl-N-<4-hydroxy-phenyl>-thioharnstoff-glucuronid|O1-[4-(N-phenyl-thioureido)-phenyl]-beta-D-glucopyranuronic acid|O1-[4-(N-Phenyl-thioureido)-phenyl]-beta-D-glucopyranuronsaeure
C19H20N2O7S (420.09911700000004)
5-O-(beta-D-glucopyranosyl)-6-O-benzoyl-2,5-dihydroxybenzoic acid|shomaside F
5-Hydroxy-3-methoxy-1-O-beta-D-glucopyranosylxanthone
3-((3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
Cassiaside2,3,4-Trihydroxy-3,5-dimethoxypropiophenoneGinsenoside Rg4Methyl dihydrojasmonate1-Dehydroxy-23-deoxojessic acidMalvidin-3-galactoside chlorideTropine4,5-Dioxodehydroasimilobine(2R,3R)-3,7-Dihydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-en-1-yl)chroman-4-one
Cassiaside is a naphthopyrone glucoside, shows mixed-type inhibition against BACE1 (IC50=4.45 μM; Ki=9.85 μM). Cassiaside possesses potential anti- Alzheimer's disease (AD) activity[1]. Cassiaside is a naphthopyrone glucoside, shows mixed-type inhibition against BACE1 (IC50=4.45 μM; Ki=9.85 μM). Cassiaside possesses potential anti- Alzheimer's disease (AD) activity[1].
Asp Asp Asp Gly
Asp Asp Gly Asp
Asp Gly Asp Asp
Gly Asp Asp Asp
Ile-Phe4Cl-OH
C20H21ClN2O6 (420.10880760000003)
Leu-Phe4Cl-OH
C20H21ClN2O6 (420.10880760000003)
Met-Tyr-OH
C19H20N2O7S (420.09911700000004)
Phe4Cl-Leu-OH
C20H21ClN2O6 (420.10880760000003)
Phe4Cl-Ile-OH
C20H21ClN2O6 (420.10880760000003)
Bismurrayaquinone A
doripenem
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DH - Carbapenems D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
HCV-086
3-Isopropoxy-5-[1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-3-yl] benzaldehyde
C23H20N2O4S (420.11437200000006)
2,2,4,6,6,8-hexamethyl-4,8-diphenyl-1,3,5,7,2,4,6,8-tetraoxatetra silocane
C18H28O4Si4 (420.10646080000004)
2-ethyl-6-hydroxy-5-[(2-methoxy-4-nitrophenyl)azo]-1H-benz[de]isoquinoline-1,3(2H)-dione
N-[(1R,2R)-2-aMino-1,2-diphenylethyl]-4-(trifluoroMethyl)-BenzenesulfonaMide
C21H19F3N2O2S (420.11192700000004)
(4E)-4-[[4-[(E)-(5-oxo-2-phenyl-1,3-oxazol-4-ylidene)methyl]phenyl]methylidene]-2-phenyl-1,3-oxazol-5-one
(2r)-N-Hydroxy-3-Naphthalen-2-Yl-2-[(Naphthalen-2-Ylsulfonyl)amino]propanamide
C23H20N2O4S (420.11437200000006)
5-[(3,3-Dimethyl-2-oxido-1-triazen-1-yl)oxy]-2,4-dinitrophenyl 4-(methylamino)benzoate
C16H16N6O8 (420.10295759999997)
4-[5-[3-(Methylsulfonyl)phenyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]benzenepropanoic acid
C23H20N2O4S (420.11437200000006)
(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-1-ium-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
[3-Amino-6-(4-methoxyphenyl)-2-thieno[2,3-b]pyridinyl]-(3,4-dimethoxyphenyl)methanone
C23H20N2O4S (420.11437200000006)
1-(2-Fluorophenyl)-1-cyclopentanecarboxylic acid [2-oxo-2-(4-sulfamoylanilino)ethyl] ester
1-(4-Fluorophenyl)-1-cyclopentanecarboxylic acid [2-oxo-2-(4-sulfamoylanilino)ethyl] ester
2-amino-N-[3-methoxy-5-[oxo-[3-(trifluoromethyl)anilino]methyl]phenyl]-5-oxazolecarboxamide
2-[[Cyclohexyl(oxo)methyl]amino]acetic acid [2-[2-chloro-5-(trifluoromethyl)anilino]-2-oxoethyl] ester
C18H20ClF3N2O4 (420.10636260000007)
2-[3-[(2-Chlorophenyl)methyl]-2-imino-1-benzimidazolyl]-1-(4-nitrophenyl)ethanone
3-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-5,7-dihydroxy-2-(3-hydroxyphenyl)-2,3-dihydrochromen-4-one
(4S,5R,6R)-6-[(1S)-1-hydroxyethyl]-4-methyl-7-oxo-3-({(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl}sulfanyl)-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
SirReal2
SirReal2 is a potent, isotype-selective Sirt2 inhibitor with an IC50 value of 140?nM and has very little effect on the activities of Sirt3-5. SirReal2 leads to tubulin hyperacetylation in HeLa cells and induces destabilization of the checkpoint protein BubR1[1].
1,3-dihydroxy-7-methoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]xanthen-9-one
(2s,3r,4r,5s)-5-[2-(3,5-dihydroxybenzoyl)-3-hydroxyphenoxy]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl acetate
(1s,12as,13r,14r,15ar)-1-ethyl-13-hydroxy-14-iodo-1h,4h,5h,6h,7h,8h,9h,10h,12ah,13h,14h,15h,15ah-cyclopenta[c]oxacyclotetradecan-3-one
C18H29IO3 (420.11613539999996)